Al M, Michel B, Rutten F
Pharmacoeconomics. 1996; 10(2):141-51.
PMID: 10163417
DOI: 10.2165/00019053-199610020-00006.
Silverstein F
Dig Dis Sci. 1998; 43(3):447-58.
PMID: 9539636
DOI: 10.1023/a:1018895417831.
Ching C, Lam S
J Gastroenterol. 1995; 30(5):607-14.
PMID: 8574332
DOI: 10.1007/BF02367786.
Taha A, Dahill S, Nakshabendi I, Lee F, Sturrock R, Russell R
Gut. 1993; 34(9):1162-6.
PMID: 8406146
PMC: 1375446.
DOI: 10.1136/gut.34.9.1162.
Melo Gomes J, Roth S, Zeeh J, Bruyn G, Woods E, Geis G
Ann Rheum Dis. 1993; 52(12):881-5.
PMID: 8311540
PMC: 1005220.
DOI: 10.1136/ard.52.12.881.
Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.
Goggin P, Collins D, Jazrawi R, Jackson P, Corbishley C, Bourke B
Gut. 1993; 34(12):1677-80.
PMID: 8282254
PMC: 1374461.
DOI: 10.1136/gut.34.12.1677.
Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.
Kelly S, Jenner J, Dickinson R, Hunter J
Gut. 1994; 35(5):611-4.
PMID: 8200552
PMC: 1374742.
DOI: 10.1136/gut.35.5.611.
Helicobacter pylori infection. Implications for ulcer therapy in older patients.
Buckley M, MARTIN P, OMorain C
Drugs Aging. 1994; 5(1):1-7.
PMID: 7919636
DOI: 10.2165/00002512-199405010-00001.
Postsurgical complications in older patients. The role of pharmacological intervention.
Zuccala G, Cocchi A, Gambassi G, Bernabei R, Carbonin P
Drugs Aging. 1994; 5(6):419-30.
PMID: 7858368
DOI: 10.2165/00002512-199405060-00004.
Gastrointestinal damage induced by anti-inflammatory drugs.
Upadhyay R, McKinlay A, Russell R
BMJ. 1988; 297(6661):1474.
PMID: 3147035
PMC: 1835126.
DOI: 10.1136/bmj.297.6661.1474.
Anaemia in rheumatoid arthritis.
Doube A
Ann Rheum Dis. 1989; 48(3):262.
PMID: 2930283
PMC: 1003734.
DOI: 10.1136/ard.48.3.262-a.
Peptic ulcer in rheumatoid arthritis.
Roth S
Ann Rheum Dis. 1989; 48(5):438-9.
PMID: 2730171
PMC: 1003779.
DOI: 10.1136/ard.48.5.438.
Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: to be considered in certain circumstances.
Doherty M
BMJ. 1989; 298(6667):176, 178-9.
PMID: 2493844
PMC: 1835503.
DOI: 10.1136/bmj.298.6667.176.
Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration.
Kelly S, Crampton J, Hunter J
BMJ. 1990; 301(6749):422-3.
PMID: 2282399
PMC: 1663684.
DOI: 10.1136/bmj.301.6749.422.
Drug toxicity.
Bird H
Ann Rheum Dis. 1990; 49(5):331-6.
PMID: 2188624
PMC: 1004083.
DOI: 10.1136/ard.49.5.331.
Non-steroidal anti-inflammatory drugs and peptic ulcers.
Hawkey C
BMJ. 1990; 300(6720):278-84.
PMID: 2106956
PMC: 1661907.
DOI: 10.1136/bmj.300.6720.278.
Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
Hawthorne A, Mahida Y, Cole A, Hawkey C
Br J Clin Pharmacol. 1991; 32(1):77-83.
PMID: 1888645
PMC: 1368496.
DOI: 10.1111/j.1365-2125.1991.tb05616.x.
Effect of misoprostol on concentrations of prostaglandins in synovial fluid.
Doube A, Davies J, Notarianni L, Holgate K, Fenn G
Ann Rheum Dis. 1991; 50(11):797-9.
PMID: 1772296
PMC: 1004561.
DOI: 10.1136/ard.50.11.797.
Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs.
Taha A, Boothman P, Nakshabendi I, Reid J, Morran C, Gemmell C
J Clin Pathol. 1992; 45(8):709-12.
PMID: 1401184
PMC: 495151.
DOI: 10.1136/jcp.45.8.709.
Ankylosing spondylitis. Current drug treatment.
Gran J, Husby G
Drugs. 1992; 44(4):585-603.
PMID: 1281074
DOI: 10.2165/00003495-199244040-00006.